Merck Millipore Launches the Muse Cell Analyzer
Merck Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announced the launch of the Muse Cell Analyzer system for real-time quantitative assessment of cell concentration, cell health, apoptosis, and cell cycle with greater accuracy and precision than manual hemocytometry or image-based automated analysis.
By providing real-time, multi-dimensional information on cell populations, the Muse cell analyzer enables faster, more accurate decision-making, more productive workflows, and greater insight in to cell health.
This system delivers high-performance cell analysis using patent-pending, miniaturized fluorescent detection and microcapillary technology which occupy one-tenth the space of a typical cytometer. Laser-based fluorescence detection of each cell event can evaluate up to three cellular parameters. As a result, Muse provides accurate quantitative results compared to imaging-based systems, which only examine up to two parameters, are time-consuming and ultimately provide less quantitative data. The system is capable of analyzing both suspension and adherent cells from two to sixty μm in diameter. Intuitive software and simple touchscreen interface enable rapid set-up and analysis.
To further optimize workflows, the Muse Cell Analyzer is designed to work with all-in-one kits, specifically validated for robust performance on the system. Kits include cell count and viability, apoptosis and cell cycle and come with all the reagents necessary for proper sample preparation.